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OBJECTIVE — To evaluate the impact of an exercise program organized into supervised
walking groups in subjects with type 2 diabetes.
RESEARCH DESIGN AND METHODS — Fifty-nine diabetic subjects were random-
ized to a control group receiving standard lifestyle recommendations or an intervention group
assigned to three supervised walking sessions per week and counseling. Changes in metabolic
features, weight, 6-min walk test, prescription of antidiabetic medications, and overall physical
activity were assessed.
RESULTS — Functional capacity and overall physical activity were higher in the intervention
group, whereas metabolic changes were not different between groups after 4 months. However,
insubjectswhoattendedatleast50%ofscheduledwalkingsessions,changesinA1Candfasting
glucoseweregreaterthanincontrolsubjects.Discontinuationorreductionofantidiabeticdrugs
occurred in 33% of these patients versus 5% of control subjects (P  0.05).
CONCLUSIONS — Supervisedwalkingmaybebeneﬁcialindiabeticsubjects,butmetabolic
improvement requires adequate compliance.
Diabetes Care 33:2333–2335, 2010
E
xercise can attenuate hyperglycemia
indiabeticsubjects(1,2)andalsore-
duces cardiovascular events (3,4).
However, it still remains unclear how this
evidence can be transferred into clinical
practice, considering the very large size
and the characteristics of the diabetic
population, made up predominantly
of elderly, sedentary, and overweight
patients.
Walking is a typical mild-moderate
aerobic exercise that is easy to organize
and does not require speciﬁc skills, ex-
pensive equipment, or sophisticated pre-
liminary medical evaluations. However,
self-paced walking seems inadequate to
improve metabolic control in these
patients (5).
In this pilot study, we assessed the
feasibility and effectiveness of an inter-
vention based on the organization of su-
pervised walking groups.
RESEARCH DESIGN AND
METHODS— Fifty-nine subjects
were recruited from the Diabetic Out-
patient Clinic of the City Hospital of
Verona, Italy. Inclusion criteria were
type 2 diabetes known for at least 2
years, physical inactivity, age 50–75
years, and A1C 6.5–9.9%. Admitted
treatmentswerediet,oralhypoglycemic
agents, and bedtime insulin. Exclusion
criteria were moderate-severe complica-
tions of diabetes, intercurrent diseases, use
of -blockers, and unsuitability for the ex-
ercise program.
A1C,fastingglucose,andlipidproﬁle
were measured, and functional capacity
was assessed by a 6-min walk test (6-
mWT) (6). Patients were asked to record
all physical activities, to estimate energy
expenditure (7), and to perform home
blood glucose monitoring.
Subjects were assigned with a 1:2 ra-
tio, by a randomization table, into a con-
trol group (n  21) or an intervention
group(n39).Controlsubjectsreceived
standard instructions aimed at encourag-
ing physical activity. The intervention
group was organized into walking
groups, and exercised three times weekly
for45minunderthesupervisionofaper-
sonal trainer. Intensity of exercise was in-
creased gradually from low to moderate.
Beforestartingtheprogramand2months
thereafter, these subjects participated in
one individual and one group counseling
session (8).
An interim visit was scheduled after 2
months to adjust, if necessary, antidia-
betic treatments. Patients were instructed
toaskforadditionalvisitsiftheyrecorded
hypoglycemias and to maintain an isoca-
loric diet.
After 4 months, baseline procedures
were repeated. The efﬁcacy of interven-
tion was established by changes in A1C
(primary outcome) and other metabolic
parameters, attendance at the walking
sessions, changes in overall physical
activity and distance traveled in the
6-mWT, and variation in prescription of
antidiabetic medications.
ThestudywasapprovedbytheEthics
Committee of Verona Hospital, and par-
ticipants gave their written informed
consent.
Between- and within-group compari-
sons were conducted with Student t test
for unpaired and paired data, ANOVA for
repeated measures, and Fisher test for
multiple comparisons. Univariate regres-
sion analyses were used to correlate
changes in relevant parameters. Skewed
variables were log-transformed before
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compare changes in antidiabetic therapy
between groups. Results are shown as
meansSD.Thelevelofsigniﬁcancewas
P  0.05.
RESULTS— At baseline, the two
groups were similar. Eight subjects in the
intervention group abandoned the proto-
col because of lack of time (n  5) or
persistentarticularpain(n3).Onesub-
jectwasexcludedbecauseofdifﬁcultiesin
completing the walking sessions. One
subject in the control group was lost to
follow-up.
In the intervention group 7 of 39 and
in the control group 1 of 21 subjects re-
ported mild hypoglycemias (P  NS).
By intention-to-treat analysis, at the
end of the study the intervention group
showedsigniﬁcantreductionsinA1Cand
total cholesterol (0.12 mg/dl [0.37%]
and 6.4 mg/dl [18.5%], respectively,
both P  0.05). However, differences in
metabolic improvement between groups
did not reach statistical signiﬁcance. Dis-
tance covered in the 6-mWT and calcu-
lated energy expenditure increased in
both groups. However, changes were
greater in the intervention group (both
P  0.01). Change in overall physical ac-
tivity correlated with reduction in body
weight (r  0.51, P  0.005).
Average attendance at walking ses-
sions was 60%. Because there was a wide
individual range (14–90%) in participa-
tion in scheduled activities, a secondary
analysis was carried out including only
subjects whose attendance was at least
50% (n  21). Table 1 shows changes
observed in this subgroup and in control
subjects.ChangesinA1C,fastingglucose,
distance covered in the 6-mWT, and en-
ergy expenditure were signiﬁcantly
greater in these subjects than in control
subjects. Reduction or discontinuation of
antidiabetic drugs occurred in 33% of pa-
tientsintheinterventiongroupversus5%
of control subjects (P  0.05).
In multivariate analyses, A1C reduc-
tion was predicted by baseline A1C and
BMI, but not by sex, baseline physical ac-
tivity, or functional capacity. Compliance
was predicted only by the female sex.
CONCLUSIONS— In our study,
several patients included in the interven-
tiongroupdidnotcompletetheprogram,
and remaining subjects attended only
60% of the scheduled sessions. Accord-
ingly, reduction of A1C levels, the pri-
mary outcome, was not signiﬁcantly
different from that in control subjects.
However, the improvement in functional
capacity and energy expenditure was
greater in the intervention group. This
difference was not entirely explained by
participation in supervised walking, indi-
cating an active effort by many patients of
this group to increase physical activity.
Moreover, in a secondary analysis carried
out in subjects whose attendance in
scheduled activities was at least 50%,
changes in A1C were higher than in con-
trol subjects.
Interestingly,prescriptionofantidi-
abetic medications was reduced in 33%
of subjects in the intervention group
versus only 5% in the control group.
These data add value to the differences
in metabolic control changes between
groups, strongly supporting the efﬁcacy
of this model in diabetic subjects with
adequate compliance.
Until now, only a few small-sized
studies assessed the efﬁcacy of walking in
diabeticsubjects,andresultswerecontro-
versial (9–12). Notably, because of the
low walking speed typical of diabetic pa-
tients, self-paced walking seems insufﬁ-
cient to improve the metabolic control in
thesesubjects(5).Ourstudyaddstothese
ﬁndings by showing that organization of
supervised walking groups may be bene-
ﬁcial from several points of view in these
subjects, provided that attendance is at
least 50% of scheduled sessions.
In conclusion, supervised walking
may induce favorable metabolic changes
Table 1—Comparison of changes observed in subjects who attended at least 50% of supervised walking sessions and in control subjects
Intervention group Control group
P Baseline 4 months Baseline 4 months
n 21 21 20 20
Age (years) 65.7  4.9 65.7  5.2
Duration of diabetes (years) 10.7  7.4 11.9  8.4
Body weight (kg) 75.4  11.5 74.5  11.3 77.7  12.7 77.4  12.8 0.49
BMI (kg/m
2) 29.2  4.2 28.9  4.2 29.5  4.9 29.3  4.7 0.63
A1C (%) 7.50  0.72 7.23  0.64* 7.39  0.48 7.34  0.53 0.01
Glucose (mg/dl) 154  39.5 140  29.8† 148  20.4 150  25.8 0.05
Total cholesterol (mg/dl) 179  32 175  28 177  34 178  36 0.32
HDL cholesterol (mg/dl) 51.4  10.9 52.0  12.4 54.7  11.4 52.7  11.1 0.29
LDL cholesterol (mg/dl) 104.2  29.8 100.9  25.1 98.9  28.4 101.6  29.5 0.24
Triglyceride (mg/dl) 119  51.1 109  49.4 116  43.0 118  48.4 0.21
Systolic blood pressure (mmHg) 133  14.5 134  13.9 133  16.0 134  16.1 0.96
Diastolic blood pressure (mmHg) 80  6.2 78  7.1 75  6.5 77  8.0 0.15
6-mWT (m) 521  37.2 612  78.8* 554  49.2 574  60.8† 0.001
Energy expenditure through voluntary physical
activity (MET h  week) 10.0  11.2 18.6  10.1* 11.9  11.9 14.9  10.3 0.008
Changes to antidiabetic medication regimen
Dose increased — 5 — 5
Dose decreased or therapy discontinued — 33 — 5 0.05
No change to regimen — 62 — 90
DataaremeansSDorpercent,unlessotherwiseindicated.PvaluesrefertocomparisonbetweeninterventionandcontrolgroupsbyANOVAforrepeatedmeasures
or, for comparison in changes to antidiabetic regimen, by Fisher exact test. In this analysis, subjects were grouped according to whether or not they had a reduction
in antidiabetic medications. *0.001 intragroup comparison; †0.05 intragroup comparison.
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betic subjects, but compliance remains a
crucial issue. This model was associated
with a reduced prescription of antidia-
beticdrugs,suggestinganimprovedqual-
ity of life as well as a ﬁnancial saving.
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